SEARCH

SEARCH BY CITATION

References

  • ALTMAN, J.D., TRENDELENBURG, A.U., MACMILLAN, L., BERNSTEIN, D., LIMBIRD, L., STARKE, K., KOBILKA, B.K. & HEIN, L. (1999). Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice. Mol. Pharmacol., 56, 154161.
  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 4858.
  • BERZETEI-GURSKE, I.P., SCHWARTZ, R.W. & TOLL, L. (1996). Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol., 302, R1R2.
  • BILSKI, A.J., HALLIDAY, S.E., FITZGERALD, J.D. & WALE, J.L. (1983). The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430437.
  • BLAKELEY, A.G.H., DUNN, P.M. & PETERSEN, S.A. (1988). A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro. Br. J. Pharmacol., 94, 3746.
  • CALÒ, G., RIZZI, A., BOGONI, G., NEUGEBAUER, V., SALVADORI, S., GUERRINI, R., BIANCHI, C. & REGOLI, D. (1996). The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol., 311, R3R5.
  • CHULAK, C., COUTURE, R. & FOUCART, S. (1998). Modulatory effect of bradykinin on noradrenaline release in isolated atria from normal and B2 knockout transgenic mice. Eur. J. Pharmacol., 346, 167174.
  • COSTA, M. & MAJEWSKI, H. (1991). Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br. J. Pharmacol., 102, 855860.
  • COX, S.L., SCHELB, V., TRENDELENBURG, A.U. & STARKE, K. (2000). Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between Gq/11 protein- and Gi/o protein-coupled receptors. Br. J. Pharmacol., 129, 10951102.
  • COX, S.L., TRENDELENBURG, A.U. & STARKE, K. (1999). Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br. J. Pharmacol., 127, 12561262.
  • DHAWAN, B.N., CESSELIN, F., RAGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567592.
  • DRIESSEN, B., BÜLTMANN, R., GONÇALVES, J. & STARKE, K. (1996). Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional β-adrenoceptors: evidence for the β2 subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 564571.
  • EMMERSON, P.J., LIU, M.R., WOODS, J.H. & MEDZIHRADSKY, F. (1994). Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther., 271, 16301637.
  • ENDO, T., STARKE, K., BANGERTER, A. & TAUBE, H.D. (1977). Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 296, 229247.
  • EXNER, H.J. & SCHLICKER, E. (1995). Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 4652.
  • FALCONE, R.C., HUBBS, S.J., VANDERLOO, J.D., PROSSER, J.C., LITTLE, J., GOMES, B., AHARONY, D. & KRELL, R.D. (1993). Characterization of bradykinin receptors in guinea pig gall bladder. J. Pharmacol. Exp. Ther., 266, 12911299.
  • FOUCART, S. & MAJEWSKI, H. (1989). Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 658665.
  • FUDER, H. & MUSCHOLL, E. (1995). Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev. Physiol. Biochem. Pharmacol., 126, 265412.
  • GUERRINI, R., CALO, G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163165.
  • HEIN, L., ALTMAN, J.D. & KOBILKA, B.K. (1999). Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission. Nature, 402, 181184.
  • HENDERSON, G., HUGHES, J. & KOSTERLITZ, H.W. (1972). A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br. J. Pharmacol., 46, 764766.
  • HENDERSON, G. & MCKNIGHT, A.T. (1997). The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci., 18, 293300.
  • HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769773.
  • ILLES, P. (1989). Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev. Physiol. Biochem. Pharmacol., 112, 139233.
  • ISHAC, E.J.N., JIANG, L., LAKE, K.D., VARGA, K., ABOOD, M.E. & KUNOS, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 20232028.
  • JOHNSTON, H. & MAJEWSKI, H. (1986). Prejunctional β-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of α-adrenoceptor blockade and phosphodiesterase inhibition. Br. J. Pharmacol., 87, 553562.
  • LANGER, S.Z. (1981). Presynaptic regulation of the release of catecholamines. Pharmacol. Rev., 32, 337362.
  • LIMBERGER, N., TRENDELENBURG, A.U. & STARKE, K. (1995). Subclassification of presynaptic α2-autoreceptors: α2D-autoreceptors in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 4348.
  • LLONA, I., GALLEGUILLOS, X., BELMAR, J. & HUIDOBRO-TORO, J.P. (1991). Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci., 48, 25852592.
  • MAJEWSKI, H. (1983). Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J. Auton. Pharmacol., 3, 4760.
  • MOLDERINGS, G., LIKUNGU, J., ZERKOWSKI, H.R. & GÖTHERT, M. (1988). Presynaptic β2-adrenoceptors on the sympathetic nerve fibres of the human saphenous vein: no evidence for involvement in adrenaline-mediated positive feedback loop regulating noradrenergic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 408414.
  • PERTWEE, R.G., FERNANDO, S.R., NASH, J.E. & COUTTS, A.A. (1996). Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 21992205.
  • PERTWEE, R.G., GRIFFIN, G., LAINTON, J.A.H. & HUFFMAN, J.W. (1995). Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 284, 241247.
  • PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980984.
  • RAJANAYAGAM, M.A.S., MUSGRAVE, I.F., RAND, M.J. & MAJEWSKI, H. (1989). Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery. Arch. Int. Pharmacodyn., 299, 185199.
  • RAMME, D., ILLES, P., SPÄTH, L. & STARKE, K. (1986). Blockade of α2-adrenoceptors permits the operation of otherwise silent opioid κ-receptors at the sympathetic axons of rabbit jejunal arteries. Naunyn-Schmiedeberg's Arch. Pharmacol., 334, 4855.
  • RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J.C. & LE FUR, G. (1994). SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letts., 350, 240244.
  • RUMP, L.C., BERLIT, T., SCHWERTFEGER, E., BEYERSDORF, F., SCHOLLMEYER, P. & BOHMANN, C. (1997). Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium. J. Hypertension, 15, 12631270.
  • SCHLICKER, E., BEHLING, A., LÜMMEN, G. & GÖTHERT, M. (1992). Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 489493.
  • SCHLICKER, E. & GÖTHERT, M. (1998). Interactions between the presynaptic α2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res. Bull., 47, 129132.
  • SCHLICKER, E., TIMM, J., ZENTNER, J. & GÖTHERT, M. (1997). Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 583589.
  • SCHLICKER, E., WERTHWEIN, S., KATHMANN, M. & BAUER, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 418422.
  • SEYEDI, N., WIN, T., LANDER, H.M. & LEVI, R. (1997). Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Circ. Res., 81, 774784.
  • SINGER, E.A. (1988). Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol. Sci., 9, 274276.
  • STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1124.
  • STARKE, K., PESKAR, B.A., SCHUMACHER, K.A. & TAUBE, H.D. (1977). Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol., 299, 2332.
  • TRENDELENBURG, A.U., HEIN, L., GAISER, E.G. & STARKE, K. (1999). Occurrence, pharmacology and function of presynaptic α2-autoreceptors in α2A/D-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 540551.
  • TRENDELENBURG, A.U., SUTEJ, I., WAHL, C.A., MOLDERINGS, G.J., RUMP, L.C. & STARKE, K. (1997). A re-investigation of questionable subclassifications of presynaptic α2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 721737.
  • VAZ-DA-SILVA, M., MAGINA, S., DOMINGUES-COSTA, A., MOURA, D. & GUIMARÃES, S. (1996). The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle. Br. J. Pharmacol., 118, 364368.
  • VON KÜGELGEN, I., SCHÖFFEL, E. & STARKE, K. (1989). Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 522532.
  • WAHL, C.A., TRENDELENBURG, A.U. & STARKE, K. (1996). Presynaptic α2-autoreceptors in mouse heart atria: evidence for the α2D subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 253261.
  • WAUD D.R. (1976). Analysis of dose-response relationships. In: Advances in general and cellular pharmacology. Vol 1. ed. Narahshi, T. & Bianchi, C.P. pp 145178. New York, London: Plenum.
  • WILD, K.D., CARLISI, V.J., MOSBERG, H.I., BOWEN, W.D., PORTOGHESE, P.S., SULTANA, M., TAKEMORI, A.E., HRUBY, V.J. & PORRECA, F. (1993). Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. J. Pharmacol. Exp. Ther., 264, 831838.